Understanding Retinoblastoma
Retinoblastoma is a rare form of eye cancer that primarily affects young children, typically under the age of five. It originates in the retina, the light-sensitive layer of tissue at the back of the eye.
One of the most concerning aspects of Retinoblastoma is its early onset and potential impact on vision if left untreated. Often, the first noticeable sign is a white glow or a white pupil in flash photographs, commonly referred to as “cat’s eye reflex.” Other symptoms may include a noticeable strabismus (crossed eyes), redness or swelling of the eye, and vision problems.
Retinoblastoma can be hereditary or non-hereditary. In hereditary cases, the risk of developing retinoblastoma can be passed down from parent to child. Non-hereditary cases occur sporadically and are not linked to family history.
Early detection and treatment are crucial for the successful management of retinoblastoma. Treatment options may include chemotherapy, radiation therapy, cryotherapy (freezing), laser therapy, and in some cases, surgical removal of the affected eye (enucleation). The choice of treatment depends on factors such as the size and location of the tumor, whether the cancer has spread, and the child’s overall health.
At SRM Foundation, we understand the emotional and financial challenges that families face when dealing with a diagnosis of retinoblastoma. Our mission is to provide support and assistance to these families, offering access to medical care, financial aid, and emotional support throughout their journey. Together, we can make a difference in the lives of children battling retinoblastoma and their families.
Join us in our fight against retinoblastoma. Together, we can bring hope and healing to those in need.
